Cargando…

Biosimilar Gene Therapy: Investigational Assessment of Secukinumab Gene Therapy

OBJECTIVE: Tumor necrosis factor-alpha (TNF-α), checkpoint inhibitors, and interleukin-17 (IL-17) are critical targets in inflammation and autoimmune diseases. Monoclonal antibodies (mAbs) have a successful portfolio in the treatment of chronic diseases. With the current progress in stem cells and g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fallah, Ali, Estiri, Hajar, Parrish, Elizabeth, Soleimani, Mansoureh, Zeinali, Sirous, Zadeh-Vakili, Azita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royan Institute 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722441/ https://www.ncbi.nlm.nih.gov/pubmed/31376325 http://dx.doi.org/10.22074/cellj.2020.6309

Ejemplares similares

Multiple Sclerosis Gene Therapy Using Recombinant Viral Vectors: Overexpression of IL-4, IL-10 and Leukemia Inhibitory Factor in Wharton’s Jelly Stem Cells in The EAE Mice Model
por: Hosseini, Ahmad, et al.
Publicado: (2017)

Lentiviral Mediating Genetic Engineered Mesenchymal Stem Cells for Releasing IL-27 as a Gene Therapy Approach for Autoimmune Diseases
por: Hajizadeh-Sikaroodi, Shohreh, et al.
Publicado: (2014)

A Large Cohort Study of Genotype and Phenotype Correlations of Beta- Thalassemia in Iranian Population
por: Maryami, Fereshteh, et al.
Publicado: (2015)

Stable Knockdown of Adenosine Kinase by Lentiviral Anti-ADK miR-shRNAs in Wharton’s Jelly Stem Cells
por: Estiri, Hajar, et al.
Publicado: (2018)

In silico design, construction and cloning of Trastuzumab humanized monoclonal antibody: A possible biosimilar for Herceptin
por: Akbarzadeh-Sharbaf, Soudabeh, et al.
Publicado: (2012)

Secukinumab Therapy in Refractory Juvenile Idiopathic Arthritis
por: Nelson, Meghan Corrigan, et al.
Publicado: (2023)

Secukinumab for rheumatology: development and its potential place in therapy
por: Koenders, Marije I, et al.
Publicado: (2016)

Novel Presentation of Terminal Ileitis Associated with Secukinumab Therapy
por: Ahmed Shaheen, Aciel, et al.
Publicado: (2021)

Antimullerian Hormone and Its Receptor Gene Expression in Prenatally Androgenized Female Rats
por: Daneshian, Zahra, et al.
Publicado: (2015)

Alopecia Areata After Initiation of Secukinumab Therapy for Plaque Psoriasis
por: Choi, Esther, et al.
Publicado: (2023)

Association of miR-34a and miR-143 levels with PPARγ gene expression in adipose tissues of non-diabetic adults
por: Zarkesh, Maryam, et al.
Publicado: (2022)

Efficient Lentiviral Transduction of Adipose Tissue-Derived Mouse Mesenchymal Stem Cells and Assessment of Their Penetration in Female Mice Cervical Tumor Model
por: Kenarkoohi, Azra, et al.
Publicado: (2014)

Identification immune response genes in psoriasis after treatment with secukinumab
por: Wang, Jing, et al.
Publicado: (2023)

Efficacy and Safety of Secukinumab in Chronic Plaque Psoriasis and Psoriatic Arthritis Therapy
por: Gisondi, Paolo, et al.
Publicado: (2014)

The Clinical Implications of Nocebo Effects for Biosimilar Therapy
por: Colloca, Luana, et al.
Publicado: (2019)

Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature
por: Galluzzo, Marco, et al.
Publicado: (2019)

Obituary, Dr. Saleh Zahedi-Asl
por: Azizi, Fereidoun, et al.
Publicado: (2014)

Review of Rationale, Design, and Initial Findings: Tehran Lipid and Glucose Study
por: Azizi, Fereidoun, et al.
Publicado: (2018)

Contributions and Implications of the Tehran Lipid and Glucose Study
por: Azizi, Fereidoun, et al.
Publicado: (2018)

Assessment of serum biomarkers in patients with plaque psoriasis on secukinumab
por: Morita, Akimichi, et al.
Publicado: (2020)

Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Patients That Avoided Secukinumab Switching
por: Damiani, Giovanni, et al.
Publicado: (2022)

Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women
por: Zadeh-Vakili, Azita, et al.
Publicado: (2011)

Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis
por: Rongioletti, Franco, et al.
Publicado: (2018)

The Breakthrough of Biosimilars: A Twist in the Narrative of Biological Therapy
por: Kabir, Eva Rahman, et al.
Publicado: (2019)

Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars
por: Quinlivan, Alannah, et al.
Publicado: (2022)

The Role of Kisspeptin in Female Reproduction
por: Zeydabadi Nejad, Sareh, et al.
Publicado: (2017)

The Principles of Biomedical Scientific Writing: Materials and Methods
por: Ghasemi, Asghar, et al.
Publicado: (2019)

Granuloma Annulare in the Setting of Secukinumab
por: Clark, Matthew L., et al.
Publicado: (2018)

Secukinumab in Generalized Pustular Psoriasis
por: Madanagobalane, Shraddha
Publicado: (2018)

Secukinumab on Refractory Lupus Nephritis
por: Costa, Rita, et al.
Publicado: (2021)

Secukinumab-Induced Lymphocytic Colitis
por: Gandu, Siva Santosh Kumar, et al.
Publicado: (2022)

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
por: Alonso, Sara, et al.
Publicado: (2021)

Successful secukinumab therapy in plaque psoriasis is associated with altered gut microbiota and related functional changes
por: Du, Xueshan, et al.
Publicado: (2023)

Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes
por: Vetro, Calogero, et al.
Publicado: (2022)

Practical Strategies for Advanced Practitioners Streamlining the Integration of Oncology Biosimilar Therapies Into Practice
por: Mayden, Kelley D., et al.
Publicado: (2022)

Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?
por: Monk, Bradley J., et al.
Publicado: (2017)

Chronic Inflammatory Demyelinating Polyneuropathy After Therapy With Infliximab Biosimilar
por: Larson, Jessica, et al.
Publicado: (2023)

Real-world investigation of the efficacy and safety of secukinumab for psoriasis treatment in a Chinese population
por: Zeng, Jing-Xin, et al.
Publicado: (2021)

Prenatal diagnosis of citrullinemia type 1; seven families with c.1168G [Formula: see text] A mutation of Argininosuccinate synthetase 1 gene in Southwest Iran: A case series
por: Hassanlou, Maryam, et al.
Publicado: (2023)

Successful use of secukinumab in pustular psoriasis
por: Yeung, Jensen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1noibu4jaf335v32rlpdcj6p0j